Today on Pharmaceutical Processing
Biden vows to ramp up COVID-19 vaccine distribution with $1.9T stimulus package
Amylyx hires new CFO
Regulatory See More >
Moderna and NIH assessing whether COVID-19 vaccine doses can be halved
AstraZeneca (LON:AZN) inadvertently discovered halving the first dose of its COVID-19 vaccine could boost its efficacy. Researchers at the National Institutes of Health (NIH) and Moderna (NSDQ:MRNA) are examining vaccine data to determine whether they can halve the 100-microgram dose to vaccinate twice as many people. Some data from Moderna’s clinical trial support that possibility,…
Facility See More >
Catalent to acquire Acorda’s manufacturing and packaging operations
Catalent (NYSE:CTLT) has entered into a definitive agreement to purchase a dry-powder inhaler (DPI) capsule manufacturing and packaging facility from Acorda Therapeutics (NSDQ:ACOR). The acquisition will enable Catalent to establish a center of excellence for spray-dried dispersion for DPI capsule manufacturing. The transaction will also expand Catalent’s existing U.S.-based commercial-scale capabilities in metered-dose inhalers and nasal…
Supply Chain See More >
Former FDA commissioner Kessler to help lead Biden’s COVID-19 response
President-elect Joe Biden today announced that Dr. David Kessler, who led FDA through much of the 1990s, will serve as chief science officer of his administration’s COVID-19 response. Kessler’s achievements at FDA included speeding the approval of drugs to reduce the AIDS death toll. He’ll now be helping to lead efforts to speed authorization and…
Recalls See More >
GSK, Pfizer and J&J among the most-fined drug companies, according to study
GlaxoSmithKline (LON:GSK) paid nearly $10 billion in inflation-adjusted financial penalties between January 2003 and December 2016, the highest tally for any drug company, according to research published in JAMA. That sum was more than any other in a sampling of 26 companies paying fines inside the U.S. Pfizer (NYSE: PFE) was next in line with…
Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems
Flu vaccination worries rise in South Korea following deaths
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
